Management of the Nodal Basin

  • Alfredo Guglielmi
  • Fabio Bagante
  • Andrea Ruzzenente
  • Tommaso Campagnaro
  • Simone Conci
  • Calogero IaconoEmail author


The role of lymphadenectomy for intrahepatic cholangiocarcinoma (ICC) is still debated. In fact, there is no consensus on both the extent of lymphadenectomy and on the lymph node basins that should be harvested. While the majority of centers do not perform lymphadenectomy as part of the standard surgical treatment of ICC, some authors have proposed to perform lymphadenectomy on all ICC patients. Moreover, the last edition of the AJCC TNM staging system for ICC has included the recommendation to harvest at least six lymph nodes to achieve an adequate lymph nodal staging. Even though there is no robust evidence from randomized clinical trials supporting the lymphadenectomy for ICC, results from retrospective studies suggest that lymphadenectomy should be routinely performed as part of the standard curative-intent surgical resection of ICC to properly stage patients given the lymph node status is the most important factor associated with the prognosis of ICC patients.


Intrahepatic cholangiocarcinoma lymph node staging lymph node basin liver resection surgery of the liver lymphadenectomy minimum number of harvested lymph node 


  1. 1.
    Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma. J Gastrointest Surg. 2013;17:1917–28.CrossRefGoogle Scholar
  2. 2.
    Rahnemai-Azar AA, Weisbrod AB, Dillhoff M, et al. Intrahepatic cholangiocarcinoma: current management and emerging therapies. Expert Rev Gastroenterol Hepatol. 2017;11:439–49.CrossRefGoogle Scholar
  3. 3.
    Edge SB. American Joint Committee on Cancer: “AJCC cancer staging manual”. New York: Springer; 2010.Google Scholar
  4. 4.
    Kim Y, Moris DP, Zhang XF, et al. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol. 2017;116:643–50.CrossRefGoogle Scholar
  5. 5.
    Bagante F, Spolverato G, Weiss M, et al. Assessment of the lymph node status in patients undergoing liver resection for intrahepatic cholangiocarcinoma: the new eighth edition AJCC staging system. J Gastrointest Surg. 2018;22:52–9.CrossRefGoogle Scholar
  6. 6.
    Amin MB. American Joint Committee on Cancer, American Cancer Society: “AJCC cancer staging manual”. Chicago: American Joint Committee on Cancer, Springer; 2017.Google Scholar
  7. 7.
    Harisinghani MG. Atlas of lymph node anatomy. New York: Springer; 2013.CrossRefGoogle Scholar
  8. 8.
    Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci. 2015;22:181–96.CrossRefGoogle Scholar
  9. 9.
    de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140–5.CrossRefGoogle Scholar
  10. 10.
    Valle JW, Borbath I, Khan SA, et al. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27:v28–37.CrossRefGoogle Scholar
  11. 11.
    Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 2014;60:1268–89.CrossRefGoogle Scholar
  12. 12.
    Benson AB 3rd, D’Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. J Natl Compr Cancer Netw. 2017;15:563–73.CrossRefGoogle Scholar
  13. 13.
    Nathan H, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2010;26:269–73.CrossRefGoogle Scholar
  14. 14.
    Ronnekleiv-Kelly SM, Pawlik TM. Staging of intrahepatic cholangiocarcinoma. Hepatobiliary Surg Nutr. 2017;6:35–43.CrossRefGoogle Scholar
  15. 15.
    Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463–6.CrossRefGoogle Scholar
  16. 16.
    The Liver Cancer Study Group of Japan: “Classification of Primary Liver Cancer”. Tokyo: Kanehara; 1997.Google Scholar
  17. 17.
    The Liver Cancer Study Group of Japan: “General rules for the clinical and pathological study of primary liver cancer”. Tokyo: Kanehara; 2003.Google Scholar
  18. 18.
    Vitale A, Moustafa M, Spolverato G, et al. Defining the possible therapeutic benefit of lymphadenectomy among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma. J Surg Oncol. 2016;113:685–91.CrossRefGoogle Scholar
  19. 19.
    Nuzzo G, Giuliante F, Ardito F, et al. Improvement in perioperative and long-term outcome after surgical treatment of hilar cholangiocarcinoma: results of an Italian multicenter analysis of 440 patients. Arch Surg. 2012;147:26–34.CrossRefGoogle Scholar
  20. 20.
    Bagante F, Gani F, Spolverato G, et al. Intrahepatic cholangiocarcinoma: prognosis of patients who did not undergo lymphadenectomy. J Am Coll Surg. 2015;221:1031–1040.e1031–1034.CrossRefGoogle Scholar
  21. 21.
    Morine Y, Shimada M. The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol. 2015;50:913–27.CrossRefGoogle Scholar
  22. 22.
    Shimada K, Sano T, Nara S, et al. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery. 2009;145:411–6.CrossRefGoogle Scholar
  23. 23.
    Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahepatic cholangiocarcinoma? A review of 17 years of experience in a tertiary institution. Surgery. 2015;157:666–75.CrossRefGoogle Scholar
  24. 24.
    Zhang XF, Chen Q, Kimbrough CW, et al. Lymphadenectomy for intrahepatic cholangiocarcinoma: has nodal evaluation been increasingly adopted by surgeons over time? A national database analysis. J Gastrointest Surg. 2018;22:668–75.CrossRefGoogle Scholar
  25. 25.
    Zhang XF, Chakedis J, Bagante F, et al. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. Br J Surg. 2018;105:857–66.CrossRefGoogle Scholar
  26. 26.
    Seo S, Hatano E, Higashi T, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography predicts lymph node metastasis, P-glycoprotein expression, and recurrence after resection in mass-forming intrahepatic cholangiocarcinoma. Surgery. 2008;143:769–77.CrossRefGoogle Scholar
  27. 27.
    Sano T, Shimizu Y, Senda Y, et al. Assessing resectability in cholangiocarcinoma. Hepat Oncol. 2014;1:39–51.CrossRefGoogle Scholar
  28. 28.
    Nakayama T, Tsuchikawa T, Shichinohe T, et al. Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection. World J Surg. 2014;38:1763–8.CrossRefGoogle Scholar
  29. 29.
    Aoba T, Ebata T, Yokoyama Y, et al. Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes. Ann Surg. 2013;257:718–25.CrossRefGoogle Scholar
  30. 30.
    Conci S, Ruzzenente A, Sandri M, et al. What is the most accurate lymph node staging method for perihilar cholangiocarcinoma? Comparison of UICC/AJCC pN stage, number of metastatic lymph nodes, lymph node ratio, and log odds of metastatic lymph nodes. Eur J Surg Oncol. 2017;43:743–50.CrossRefGoogle Scholar
  31. 31.
    Kitagawa Y, Nagino M, Kamiya J, et al. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg. 2001;233:385–92.CrossRefGoogle Scholar
  32. 32.
    Gu J, Xia L, Xu B, et al. Clinical prognostic significance of regional and extended lymphadenectomy for biliary cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis. Dig Liver Dis. 2016;48:717–25.CrossRefGoogle Scholar
  33. 33.
    Shin HR, Oh JK, Masuyer E, et al. Epidemiology of cholangiocarcinoma: an update focusing on risk factors. Cancer Sci. 2010;101:579–85.CrossRefGoogle Scholar
  34. 34.
    Bagante F, Spolverato G, Weiss M, et al. Surgical management of intrahepatic cholangiocarcinoma in patients with cirrhosis: impact of lymphadenectomy on peri-operative outcomes. World J Surg. 2018;42:2551–60.CrossRefGoogle Scholar
  35. 35.
    Kim Y, Spolverato G, Amini N, et al. Surgical management of intrahepatic cholangiocarcinoma: defining an optimal prognostic lymph node stratification schema. Ann Surg Oncol. 2015;22:2772–8.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Alfredo Guglielmi
    • 1
  • Fabio Bagante
    • 1
  • Andrea Ruzzenente
    • 1
  • Tommaso Campagnaro
    • 1
  • Simone Conci
    • 1
  • Calogero Iacono
    • 1
    Email author
  1. 1.Department of SurgeryUniversity of VeronaVeronaItaly

Personalised recommendations